In April, we added 122 citations in DIDB, including 62 in vitro (with 19 articles published in May 2025) and 60 in vivo articles (with 35 articles published in May 2025).
3 NDA/BLAs approved in 2025, including atrasentan (VANRAFIA), fitusiran (QFITLIA), and nipocalimab (IMAAVY) were also curated in DIDB.
You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.
As always, feel free to contact us if you have any questions or comments.